SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ATIS is on the move!
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
2205 22 0 ATIS
Emcee:  Rick Costantino Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1230 Bill, Just to interject, I think that areas to look for are companies who do aMarshall Teitelbaum-12/15/1997
1229 Harry, Can't disagree...sorry. Exactly my viewpoint, although of course oMarshall Teitelbaum-12/15/1997
1228 Bill, I think the January effect this time may be different. I don't think Harry D. Kramer-12/15/1997
1227 Harry, I like your thinking--looking ahead around the next bend in the road. AWWS-12/15/1997
1226 Some big-picture discussion points for biotech investors: 1.) Lower interest rHarry D. Kramer-12/15/1997
1225 Hi Marshall, as always at this time of the year it's starting to get intereHarry D. Kramer-12/15/1997
1224 Bruce, What would happen with ORG depends on many factors: when/if they get oMarshall Teitelbaum-12/13/1997
1223 Marshall, That's good news for ATIS. If ORG doesn't get on the panel Bruce Long-12/13/1997
1222 Harry, Looks like basic general tech/biotech weakness during the flight to thMarshall Teitelbaum-12/12/1997
1221 Bruce, Last I looked there was no actual agenda yet posted, so don't know.Marshall Teitelbaum-12/12/1997
1220 uh huhDavid S.-12/11/1997
1219 Marshall, Have you heard anything about ORG possibly getting on the same panelBruce Long-12/10/1997
1218 David, I'm still not fully with you here. First, I don't recall you aMarshall Teitelbaum-12/10/1997
1217 Look at the relative valuation vs. Lifecell. and on, and on.David S.-12/10/1997
1216 IART is one of many companies going after the reconstructive and burn markets. David S.-12/10/1997
1215 Bill, Agreed. The full thickness burn industry is only getting more and more Marshall Teitelbaum-12/9/1997
1214 Marshall, As you do, I like to think that ATIS is a leader of the "skins&qWWS-12/9/1997
1213 Harry, Just as interesting aside about ATIS trading....interesting how the midMarshall Teitelbaum-12/9/1997
1212 Hi Bill, Long time no see here. Hope all has been going well for you. Nice tMarshall Teitelbaum-12/9/1997
1211 David, Not sure I understand the logic. IART is a company which has been gradMarshall Teitelbaum-12/9/1997
1210 No, I don't value development stage biotechs based on trailing revenue. ThDavid S.-12/9/1997
1209 DavidS, I would sure like to hear your answer to Harry's question about youWWS-12/9/1997
1208 That is possible, although not very likely. But I do not want to start an IMNX Harry D. Kramer-12/9/1997
1207 If Immunex has a problem with a certain drug that they are betting a lot on, thDavid S.-12/9/1997
1206 David, are you really trying to value biotech companies, that have just enteredHarry D. Kramer-12/9/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News